Live from the NIH registry
Studies recruiting near Bellevue right now
Top 25 of 1,520 recruiting studies, sorted by proximity — each links to its official registry page
The ED-AWARENESS-2 Trial
Awareness, Mechanical Ventilation
N/A
Interventional 3,090 participants sought
University of Washington School of Medicine — Seattle, Washington (8.4 mi)
· Sponsor: Washington University School of Medicine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
University of Washington - Fred Hutchinson Cancer Center — Seattle, Washington (8.4 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Rainier Clinical Research Center — Renton, Washington (8.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of Washington Medical Center — Seattle, Washington (8.4 mi)
· Sponsor: AskBio Inc
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
Retinoblastoma Bilateral, Retinoblastoma Unilateral
N/A
Observational 100 participants sought
University of Washington — Seattle, Washington (8.4 mi)
· Sponsor: University of Washington
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Seattle, Washington (8.4 mi)
· Sponsor: AstraZeneca
Lay-Delivered Behavioral Activation in Senior Centers
Depression
N/A
Interventional 288 participants sought
Greenwood Senior Center — Seattle, Washington (8.4 mi)
· Sponsor: University of Washington
Resilience Mobile App for Teens and Young Adults With Cancer
Cancer
N/A
Interventional 80 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi)
· Sponsor: Seattle Children's Hospital
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Seattle Children's Hospital — Seattle, Washington (8.4 mi)
· Sponsor: Nationwide Children's Hospital
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
University of Washington Medical Center- Site Number : 8400014 — Seattle, Washington (8.4 mi)
· Sponsor: Sanofi
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
FHCC Overlake — Bellevue, Washington (2.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Washington Gastroenterology- GIA — Bellevue, Washington (2.4 mi)
· Sponsor: Takeda
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Northwest Medical Specialties, PLLC — Federal Way, Washington (20.3 mi)
· Sponsor: Pfizer
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
EvergreenHealth — Kirkland, Washington (6.5 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 2
Interventional 60 participants sought
Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington (8.4 mi)
· Sponsor: University of Washington
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Saint Joseph Medical Center Hematology and Oncology - Silverdale — Silverdale, Washington (25.4 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
MultiCare Institute for Research and Innovation — Tacoma, Washington (27.3 mi)
· Sponsor: Duke University
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Seattle, Washington (8.4 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Seattle Children's Research Institute — Seattle, Washington (8.4 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring, Fragility Fracture
N/A
Interventional 48 participants sought
University of Washington - Harborview Medical Center — Seattle, Washington (8.4 mi)
· Sponsor: University of Southern California
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-076 — Seattle, Washington (8.4 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies
Hematopoietic and Lymphatic System Neoplasm
N/A
Interventional 40 participants sought
Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington (8.4 mi)
· Sponsor: Fred Hutchinson Cancer Center
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Swedish Cancer Institute — Seattle, Washington (8.4 mi)
· Sponsor: Nurix Therapeutics, Inc.
Evaluating Treatments for Suicidal Veterans With PTSD
Self-directed Violence, Post-traumatic Stress Disorder (PTSD)
N/A
Interventional 125 participants sought
VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle, Washington (8.4 mi)
· Sponsor: VA Office of Research and Development